Michael A. Arcangeli

489 total citations
10 papers, 378 citations indexed

About

Michael A. Arcangeli is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Michael A. Arcangeli has authored 10 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in Michael A. Arcangeli's work include Diabetes Management and Research (5 papers), Pancreatic function and diabetes (4 papers) and Diabetes Treatment and Management (3 papers). Michael A. Arcangeli is often cited by papers focused on Diabetes Management and Research (5 papers), Pancreatic function and diabetes (4 papers) and Diabetes Treatment and Management (3 papers). Michael A. Arcangeli collaborates with scholars based in United States. Michael A. Arcangeli's co-authors include T. T. Aoki, Gabriele E. Sonnenberg, John T. Sorensen, David E. Kelley, Asimina Mitrakou, Herbert W. Marsh, Michael Berger, Jonathan Benn, Thomas T. Aoki and Aldo A. Rossini and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Diabetes Care.

In The Last Decade

Michael A. Arcangeli

10 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Arcangeli United States 8 186 135 113 108 105 10 378
Jo Bell United States 10 274 1.5× 180 1.3× 93 0.8× 159 1.5× 176 1.7× 11 498
C. C. Connolly United States 8 155 0.8× 160 1.2× 154 1.4× 42 0.4× 102 1.0× 11 371
Jan Pigon Sweden 10 152 0.8× 228 1.7× 134 1.2× 47 0.4× 159 1.5× 12 426
M. Persson United States 10 282 1.5× 107 0.8× 51 0.5× 225 2.1× 159 1.5× 11 497
Ronald Ninnis Switzerland 8 137 0.7× 214 1.6× 65 0.6× 111 1.0× 101 1.0× 13 365
LA Velloso Brazil 8 174 0.9× 92 0.7× 103 0.9× 36 0.3× 147 1.4× 15 453
M. E. Abrams United Kingdom 12 112 0.6× 132 1.0× 81 0.7× 43 0.4× 90 0.9× 19 458
D. P. Bracy United States 14 345 1.9× 142 1.1× 126 1.1× 263 2.4× 178 1.7× 24 602
C. Verdonk United States 11 153 0.8× 299 2.2× 183 1.6× 62 0.6× 150 1.4× 13 529
Jean Louis Chiasson Canada 11 166 0.9× 379 2.8× 175 1.5× 70 0.6× 222 2.1× 13 607

Countries citing papers authored by Michael A. Arcangeli

Since Specialization
Citations

This map shows the geographic impact of Michael A. Arcangeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Arcangeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Arcangeli more than expected).

Fields of papers citing papers by Michael A. Arcangeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Arcangeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Arcangeli. The network helps show where Michael A. Arcangeli may publish in the future.

Co-authorship network of co-authors of Michael A. Arcangeli

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Arcangeli. A scholar is included among the top collaborators of Michael A. Arcangeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Arcangeli. Michael A. Arcangeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Aoki, Thomas T., et al.. (2001). Chronic Intermittent Intravenous Insulin Therapy: A New Frontier in Diabetes Therapy. Diabetes Technology & Therapeutics. 3(1). 111–123. 10 indexed citations
2.
Aoki, Thomas T., et al.. (1999). Effect Of Intensive Insulin Therapy On Progression Of Overt Nephropathy In Patients With Type 1 Diabetes Mellitus. Endocrine Practice. 5(4). 174–178. 7 indexed citations
4.
Aoki, Thomas T., et al.. (1995). Chronic intermittent intravenous insulin therapy corrects orthostatic hypotension of diabetes. The American Journal of Medicine. 99(6). 683–684. 8 indexed citations
5.
Aoki, Takeshi, et al.. (1993). Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus. The Lancet. 342(8870). 515–518. 23 indexed citations
6.
Brooks, David C., Preston R. Black, Michael A. Arcangeli, Thomas T. Aoki, & Douglas W. Wilmore. (1989). The Heated Dorsal Hand Vein: An Alternative Arterial Sampling Site. Journal of Parenteral and Enteral Nutrition. 13(1). 102–105. 25 indexed citations
7.
Kelley, David E., Asimina Mitrakou, Herbert W. Marsh, et al.. (1988). Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.. Journal of Clinical Investigation. 81(5). 1563–1571. 242 indexed citations
8.
Meistas, Mary T, et al.. (1985). Role of Muscle in CO2 Production After Oral Glucose Administration in Man. Diabetes. 34(10). 960–963. 10 indexed citations
9.
Arcangeli, Michael A., et al.. (1985). Role of muscle in CO2 production after oral glucose administration in man. Diabetes. 34(10). 960–963. 4 indexed citations
10.
Rossini, Aldo A., Michael A. Arcangeli, & George F. Cahill. (1975). Studies of Alloxan Toxicity on the Beta Cell. Diabetes. 24(5). 516–522. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026